OpenSAFELY Vaccine Coverage Report
Pfizer / Priority Group 3
Data from combined, up to 2021-03-17.
| Vaccinated at 2021-03-17 (%) | Vaccinated at 2021-03-17 (n) | Population | Vaccinated at 2021-03-10 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 45.7% | 900,508 | 1,970,227 | 45.7% | 0.0% |
| Sex | Female | 45.6% | 478,667 | 1,049,650 | 45.6% | 0.0% |
| Male | 45.8% | 421,841 | 920,577 | 45.8% | 0.0% | |
| Ethnicity | White - British | 46.6% | 563,570 | 1,208,536 | 46.6% | 0.0% |
| White - Irish | 49.0% | 8,176 | 16,702 | 48.9% | 0.0% | |
| White - Any other White background | 42.6% | 18,410 | 43,169 | 42.6% | 0.0% | |
| Mixed - White and Black Caribbean | 35.7% | 770 | 2,156 | 35.7% | 0.0% | |
| Mixed - White and Black African | 32.7% | 371 | 1,134 | 32.7% | 0.0% | |
| Mixed - White and Asian | 44.4% | 581 | 1,309 | 44.4% | 0.0% | |
| Mixed - Any other mixed background | 41.0% | 931 | 2,268 | 41.0% | 0.0% | |
| Asian or Asian British - Indian | 49.4% | 12,614 | 25,550 | 49.3% | 0.1% | |
| Asian or Asian British - Pakistani | 36.2% | 3,836 | 10,591 | 36.2% | 0.1% | |
| Asian or Asian British - Bangladeshi | 40.0% | 1,169 | 2,919 | 40.0% | 0.0% | |
| Asian or Asian British - Any other Asian background | 46.1% | 5,271 | 11,431 | 46.1% | 0.1% | |
| Black or Black British - Caribbean | 35.6% | 4,067 | 11,431 | 35.6% | 0.0% | |
| Black or Black British - African | 29.7% | 2,394 | 8,050 | 29.7% | 0.0% | |
| Black or Black British - Any other Black background | 34.7% | 609 | 1,757 | 34.3% | 0.4% | |
| Other ethnic groups - Chinese | 39.6% | 1,260 | 3,178 | 39.4% | 0.2% | |
| Other ethnic groups - Any other ethnic group | 37.3% | 2,380 | 6,384 | 37.3% | 0.0% | |
| Patients with any other ethnicity code | 45.7% | 126,595 | 276,745 | 45.7% | 0.0% | |
| Ethnicity not stated | 42.8% | 5,019 | 11,725 | 42.8% | 0.0% | |
| Ethnicity not recorded | 43.8% | 142,380 | 325,080 | 43.8% | 0.0% | |
| Ethnicity (broad categories) | White | 46.5% | 590,170 | 1,268,428 | 46.5% | 0.0% |
| Mixed | 39.0% | 2,688 | 6,888 | 38.9% | 0.1% | |
| South Asian | 45.3% | 22,897 | 50,505 | 45.3% | 0.0% | |
| Black | 33.3% | 7,070 | 21,252 | 33.3% | 0.0% | |
| Other | 38.1% | 3,647 | 9,562 | 38.1% | 0.1% | |
| Unknown | 44.7% | 274,015 | 613,564 | 44.6% | 0.0% | |
| Index of Multiple Deprivation | 1 (most deprived) | 43.0% | 111,776 | 259,721 | 43.0% | 0.0% |
| 2 | 45.5% | 151,354 | 332,647 | 45.5% | 0.0% | |
| 3 | 45.9% | 192,710 | 419,461 | 45.9% | 0.0% | |
| 4 | 46.6% | 214,277 | 459,676 | 46.6% | 0.0% | |
| 5 (least deprived) | 46.3% | 223,944 | 483,399 | 46.3% | 0.0% | |
| Unknown | 42.1% | 6,433 | 15,288 | 42.1% | 0.0% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 45.9% | 532,371 | 1,159,865 | 45.9% | 0.0% |
| Patients with Immunosuppression | 47.1% | 40,390 | 85,722 | 47.1% | 0.0% | |
| Patients with CKD | 46.1% | 148,785 | 322,896 | 46.0% | 0.0% | |
| Patients who have Chronic Respiratory Disease | 45.2% | 101,339 | 224,133 | 45.2% | 0.0% | |
| Patients with Diabetes | 45.4% | 166,621 | 367,192 | 45.3% | 0.0% | |
| Patients with Chronic Liver disease | 46.4% | 24,206 | 52,164 | 46.4% | 0.0% | |
| Patients with CNS Disease (including Stroke/TIA) | 43.5% | 92,498 | 212,800 | 43.4% | 0.0% | |
| Patients with Chronic heart disease | 46.0% | 271,621 | 591,045 | 45.9% | 0.0% | |
| Patients with Asplenia or Dysfunction of the Spleen | 47.0% | 8,064 | 17,143 | 47.0% | 0.1% | |
| Patients with Wider Learning Disability | 31.5% | 735 | 2,331 | 31.5% | 0.0% | |
| Patients with Severe Mental Health | 36.9% | 5,824 | 15,792 | 36.9% | 0.0% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 44.5% | 136,864 | 307,671 | 44.4% | 0.0% |
| Patients with Morbid Obesity | 42.2% | 20,146 | 47,768 | 42.1% | 0.0% | |
| Patients who are pregnant | 40.6% | 91 | 224 | 40.6% | 0.0% |